ID: ALA2385942

Max Phase: Preclinical

Molecular Formula: C22H19ClN2O3

Molecular Weight: 394.86

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1c2cccc3cccc(c23)C(=O)N1CCNCCOc1ccc(Cl)cc1

Standard InChI:  InChI=1S/C22H19ClN2O3/c23-16-7-9-17(10-8-16)28-14-12-24-11-13-25-21(26)18-5-1-3-15-4-2-6-19(20(15)18)22(25)27/h1-10,24H,11-14H2

Standard InChI Key:  VSODBUBVRYBSMC-UHFFFAOYSA-N

Associated Targets(Human)

Beta-N-acetyl-D-hexosaminidase-A/B 71 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 394.86Molecular Weight (Monoisotopic): 394.1084AlogP: 3.76#Rotatable Bonds: 7
Polar Surface Area: 58.64Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.81CX LogP: 3.79CX LogD: 2.37
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.49Np Likeness Score: -1.00

References

1. Guo P, Chen Q, Liu T, Xu L, Yang Q, Qian X..  (2013)  Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human β-N-Acetyl-d-hexosaminidase.,  (6): [PMID:24900704] [10.1021/ml300475m]

Source